Table 3.
Performance on RA electronic clinical quality measures, as assessed by proportion of a random sample of eligible patients receiving recommended care.
| Overall Performance | Site 1 | Site 2 | Site 3 | |
|---|---|---|---|---|
| Rheumatoid Arthritis: Assessment of Disease Activity | N=190 | N=37 | N=34 | N=119 |
| 53.60% | 89.10% | 38.20% | 59.70% | |
| Rheumatoid Arthritis: Functional Status Assessment | N=223 | N=70 | N=34 | N=119 |
| 69.10% | 62.80% | 2.90% | 93.20% | |
| Rheumatoid Arthritis: Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy | N=175 | N=81 | N=34 | N=60 |
| 93.10% | 88.90% | 94.10% | 98.30% | |
| Rheumatoid Arthritis: Tuberculosis screening | N=47 | N=66 | N=40 | N=41 |
| 72.80% | 86.40% | 67.50% | 56.10% |
N=random sample of EHR patients meeting denominator for front-end chart review.